ACLU US Senate Hearings Consider Bipartisan Proposal to Change Patent Laws; Could Have Big Impact on Dx A draft bill provides for a major expansion of eligible material, a move the ACLU and AMP said threatens to reduce competition in genetic testing. Down to the Interpretation Mother Jones reports that some data used for interpreting what BRCA1 or BRCA2 mutations mean are kept private. Experts Debate MDx Industry Impact of AMP v. Myriad Three Years After Court's Decision The US Supreme Court decision cleared the way for large-scale sequencing or drove prices to unsustainable levels, depending on your opinion. Hidden Away A cancer patient with a rare BRCA1 variant seeks better data sharing, Newsweek reports. Patients File HIPAA Complaint Against Myriad Genetics for Withholding Variant Data Four patients still want the government to investigate their allegations against Myriad, even though the firm complied with their data request at the last hour. Aug 16, 2012 Appeals Court Affirms Isolated DNA Patents in Myriad Case Jul 20, 2012 Circuit Court Re-hears Myriad Case in Wake of Prometheus Ruling Jun 15, 2012 In Brief This Week: ACLU, Myriad Genetics; Thermo Fisher Scientific, Princeton Security; EMBL-EBI; Protea Biosciences; SG Biofuels Feb 22, 2012 USPTO Hearing on Confirmatory Gene Testing Raises Calls for Reform Outside Patent System Premium Feb 20, 2012 Supreme Court Considering Taking on Gene Patents Case Jan 4, 2012 Personalized Medicine in 2011: Some Successes, Slow Progress, Continued Economic Woes Premium Dec 8, 2011 ACLU, PubPat Seek Supreme Court Review of Myriad Lawsuit Oct 13, 2011 ACLU, PUBPAT to Ask Supreme Court to Take up Gene Patenting Case Oct 13, 2011 ACLU, PUBPAT Seek to Challenge Patentability of Isolated Genes Before Supreme Court Premium Sep 7, 2011 ACLU, Myriad Separately Ask Appeals Court for Rehearing in BRCA Patent Case Premium Aug 31, 2011 Parties in Myriad BRCA Patent Suit Ask Appeals Court for Rehearing Jul 29, 2011 Appeals Court Rules Gene Patents Eligible under US Law Apr 5, 2011 Myriad, ACLU Case Hits Higher Court Dec 22, 2010 Appeals Court Says Prometheus Meets Machine/Transformation Test; Impact on Gene Patents Uncertain Premium Oct 6, 2010 Myriad Prepared to Make Small IP Sacrifice to Aussies in Light of Landmark US Patent Case Premium Jun 30, 2010 Narrow Ruling in Bilski Is a Win for Dx Developers, Despite Ambiguity on Gene-Patent Questions Premium Jun 30, 2010 Supreme Court Tasks Lower Court with Determining Criteria for Dx Patentability Premium Jun 23, 2010 Myriad to Appeal District Court's Decision in Anti-Gene Patenting Lawsuit Premium Jun 16, 2010 Australian Patient Groups Follow ACLU/PUBPAT Path in Challenging Gene Patenting Premium Mar 31, 2010 Game On: Court Ruling on Myriad Patents to Kick off Protracted Legal Battle Over DNA Patentability Premium Load More Breaking News DNAe, Imperial College London, U of Leicester to Develop NGS-Based Breast Cancer Monitoring Test Illumina, Israel Ministry of Health to Pilot Genome Sequencing for Diagnosing Critically Ill Infants GenomSys Gains CE Mark for New Genomic Analysis Software Thermo Fisher Scientific Q3 Revenues up 9 Percent BTIG Initiates Coverage of LumiraDx With Buy Rating Delic Partners With GT Research for Genetic Analysis of Cannabis, Psychedelic Mushrooms The Scan Panel Recommends Pfizer-BioNTech Vaccine for Kids CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old. Sharing How to Make It Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times. Bring it Back In Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray. Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.